Jeffrey S. Aronin
Founder & Non-Executive ChairmanMr. Jeffrey S. Aronin, also known as Jeff, is Founder of Emalex Biosciences, Inc. and has been Chairman since December 2025. He is a Co-Founder and Chairman of CiRC Biosciences, Inc. He served as Chairman of the Board at Castle Creek Biosciences, Inc. since September 2018 until August 2023 and has been its Director since September 2018. He is Director at Paragon Biosciences Skyline Capital, LLC. Mr. Aronin is Founder of Castle Creek Biosciences, Inc. He has been the Chief Executive Officer of Paragon Pharmaceuticals, LLC since January 2010. He has decades of experience developing innovative global biotech and healthcare companies. His keen ability to identify ideas and scientific innovations with the highest potential to change lives and improve the world has made. Mr. Aronin serves as its Chairman and Chief Executive Officer. He has received numerous distinctions and honors for his entrepreneurship and dedication to life sciences. In 2020, he was named as one of the Top 10 Inspiring CEOs by Insights Success magazine. In 2018, he was named Innovator of the Year by Best in Biz Awards for his lifelong commitment to developing medicines for severe diseases. That same year, Insights Care named Mr. Aronin one of the 20 Most Influential Leaders in Healthcare. He was awarded the Weizmann Leadership Award in recognition of his work to improve patients’ lives through advancements in science and technology and was presented with the Frederic A. Gibbs Discovery Award by the Brain Research Foundation. Mr. Aronin has been inducted into the Chicago Entrepreneur Hall of Fame and was also honored with the EY Entrepreneur of the Year Award. He one of the most impactful and successful leaders in the life science sector. As an entrepreneur and scientific visionary, with a focus on addressing unmet patient and societal needs, Mr. Aronin has received U.S. Food and Drug Administration (FDA) approval of nearly a dozen new medicines and technologies. His companies are renowned for advancing science, with a record number of breakthroughs helping patients and economic engines, having created thousands of job opportunities throughout the world. Mr. Aronin founded Paragon Pharmaceuticals in December 2009. He is Executive Chairman of Evozyne, Inc. Mr. Aronin serves as a Director of Evozyne, LLC and CIRC Biosciences, Inc. He served as the Chief Executive Officer of Marathon Pharmaceuticals, LLC since January 2011 until May 2017. He founded Harmony Biosciences Holdings, Inc. in 2017 and had been its No-Executive Chairman since October 2017 until January 06, 2023 and had been its Executive Chairman since January 06, 2023 until April 2023 and serves as its Non-Executive Chairman since April 2023. He served as Non-Executive Chairman of Harmony Biosciences, LLC since October 2017 until 2021. He also served as the President at Marathon Pharmaceuticals, LLC. Mr. Aronin serves as a Special Advisor at Merrick Ventures, LLC. He is the Founder of MATTER. He founded Lundbeck Inc in 2000 and has been its Strategic Advisor since December 2009. He is the Founder of Lundbeck Inc. and serves as its Strategic Advisor. He served as the Chief Executive Officer of Lundbeck Incorporated until 2011. He served as the President and Chief Operating Officer of Lundbeck Inc. until December 2009. He served as an Officer of Ceres Ventures, Inc. Mr. Aronin served as the Vice Chairman, President and Chief Operating Officer at Ovation Pharmaceuticals, Inc. from 2000 to 2009., prior to founding Ovation Pharmaceuticals in 2000 and Partnering with GTCR, he led two successful venture-backed healthcare companies. With private financial backing, Ovation Pharmaceuticals prospered under his leadership as the Chief Executive Officer. He served as the Chief Executive Officer and President at RxMarketing and MedCare Technologies, Inc. Mr. Aronin also served as the Chairman at MedCare Technologies. He served several positions at American Health Products Corporation, including Vice President of Marketing and Vice President of Business Development. Prior to American Health, he served eight years at Carter-Wallace in various sales and marketing roles, including positions with the specialty pharmaceutical sales division. At Carter-Wallace, he was involved in its specialty pharmaceutical sales force since its inception and launched one of Carter-Wallace's most promising products. He has worked at MedCare, American Health Products and Carter-Wallace. He serves on several Boards including the Epilepsy Foundation and Young President Organization. He has been the Chairman of Paragon Pharmaceuticals, LLC since January 2010. He serves as Chairman of the Patient Impact Initiative and Castle Creek Pharmaceuticals, LLC. He is Founder of Harmony Biosciences Holdings, Inc. and serves as its chairman since 2023. He served as its Executive Chairman since January 06, 2023 until 2023. He was Founder & Non-Executive Chairman of Harmony Biosciences Holdings, Inc. from October 2017. He served as a Non-Executive Chairman at Harmony Biosciences, LLC until 2019 and was Chairman of Emalex Biosciences. In June 2017, Mr. Aronin founded Paragon Biosciences LLC and serves as its Chairman and Chief Executive Officer. He is Director of Paragon Biosciences Qlarity Capital, Inc. Mr. Aronin had been an Independent Director at Discover Financial Services since June 2008 until May 10, 2024. He was Director of Discover Bank. He serves as a Board Member of Chicagoland Entrepreneurial Center. He serves as Director at the Pharmaceutical Research and Manufacturers Association (Pharmaceutical Research and Manufacturers of America, PhRMA). He serves as a Director of the University Of Chicago Medical Center, Museum of Science and Industry, World Business Chicago, Co-officer of Chicago Next, the Young President Organization and the Economic Club of Chicago Board and the Commercial Club. He is Co-Owner of Marshman Fund Trust II. He served as Chairman of Marathon Pharmaceuticals, LLC from 2010 to May 2017. He served as Vice Chairman of Lundbeck Inc. until December 2009. He served as a Member of the Board of Directors at the Medical Marketing Association. He is a Henry Crown Fellow at the Aspen Institute and the Weizmann Institute of Science. He was deemed one of the future leaders of the industry by Pharmaceutical Executive and named one of the most inspirational leaders in pharma by PharmaVOICE. He received Ernst & Young's Entrepreneur of the Year Award and is in the Illinois Entrepreneur Hall of Fame. He has experience in pharmaceuticals and finance. Mr. Aronin played an instrumental role in growing this American Health Products and assisting in the successful sale. He has experience in leading public and private pharmaceutical and life science companies. Mr. Aronin also has experience in the structuring and execution of strategic corporate transactions, including mergers and acquisitions. He is recognized as an industry-leading life sciences entrepreneur. He is a business leader, life s
Positions
- Company NameHarmony Biosciences Holdings, Inc.Stock CodeHRMYPositionFounder & Non-Executive ChairmanColleagues
- JMJeffrey M. DaynoPresident, CEO & Director
- PAPeter AnastasiouSenior Executive VP & COO
- KBKumar BudurExecutive VP and Chief Medical & Scientific Officer
- ASAndrew SerafinExecutive VP & Chief Strategy Officer
- AWAndreas WickiIndependent Director
- JAJuan Alfonso SabaterIndependent Director
- GLGary L. SenderIndependent Director
